Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The Journal of Pathology|October 26, 2011
Neuropilin-1 expression in cancer and developmentAdrian M Jubb, Laura A Strickland, Scot D Liu, et al.
Cancer Immunology Research|April 3, 2020
Anti-VEGF Treatment Enhances CD8<sup>+</sup> T-cell Antitumor Activity by Amplifying HypoxiaPatricia E de Almeida, Judy Mak, Genevive Hernandez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2018
IFNγ-induced Chemokines Are Required for CXCR3-mediated T-Cell Recruitment and Antitumor Efficacy of Anti-HER2/CD3 Bispecific AntibodyJi Li, Ryan Ybarra, Judy Mak, et al.
The Journal of Cell Biology|January 13, 2010
Neuropilin-2 mediates VEGF-C-induced lymphatic sprouting together with VEGFR3Yunling Xu, Li Yuan, Judy Mak, et al.
Blood|July 27, 2013
Rasip1 regulates vertebrate vascular endothelial junction stability through Epac1-Rap1 signalingChristopher W Wilson, Leon H Parker, Christopher J Hall, et al.
Cancer Cell|January 16, 2007
Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growthQi Pan, Yvan Chanthery, Wei-Ching Liang, et al.
Cancer Cell|April 9, 2008
Blocking neuropilin-2 function inhibits tumor cell metastasisMaresa Caunt, Judy Mak, Wei-Ching Liang, et al.
Cancer Immunology, Immunotherapy : CII|August 7, 2024
NKG2D-bispecific enhances NK and CD8+ T cell antitumor immunityAurelie Herault, Judy Mak, Josefa de la Cruz-Chuh, et al.
Frontiers in Immunology|September 26, 2019
Function of CSF1 and IL34 in Macrophage Homeostasis, Inflammation, and CancerWeiYu Lin, Daqi Xu, Cary D Austin, et al.
Pageof 1